Glucose Health, Inc.
GLUC · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,043 | $4,761 | $8,544 | $21,248 |
| - Cash | $27 | $204 | $267 | $752 |
| + Debt | $234 | $0 | $0 | $0 |
| Enterprise Value | $2,251 | $4,557 | $8,276 | $20,495 |
| Revenue | $384 | $535 | $1,073 | $954 |
| % Growth | -28.2% | -50.1% | 12.5% | – |
| Gross Profit | $76 | $216 | $457 | $410 |
| % Margin | 19.7% | 40.3% | 42.6% | 43% |
| EBITDA | -$305 | -$422 | -$562 | -$336 |
| % Margin | -79.5% | -78.9% | -52.4% | -35.2% |
| Net Income | -$316 | -$422 | -$562 | -$339 |
| % Margin | -82.3% | -78.9% | -52.4% | -35.5% |
| EPS Diluted | -0.025 | -0.029 | -0.045 | -0.026 |
| % Growth | 13.9% | 35.2% | -72.6% | – |
| Operating Cash Flow | -$455 | -$244 | -$389 | -$73 |
| Capital Expenditures | -$19 | -$0 | $0 | $0 |
| Free Cash Flow | -$474 | -$244 | -$389 | -$73 |